Phillip Md Et Al Frost is Director at Cocrystal Pharma, Inc. (COCP). SEC records also connect Frost to OPKO HEALTH, INC. (OPK) and NOCOPI TECHNOLOGIES INC (NNUP). Frost has reported 53 insider filings with the SEC since 2024. The most recent filing was in August 2026.
Every role Phillip Md Et Al Frost has reported on a Form 4, reconstructed from the filings themselves. Reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
Cocrystal Pharma, Inc. (COCP)2 filingsUpdated Aug 31, 2026
Phillip Md Et Al Frost is Director, 10% Owner of Cocrystal Pharma, Inc. (COCP). 31 SEC Form 4 filings on record going back to 2024, most recently on 6 August 2026. Most recent open-market trade: bought $10K of COCP on 6 August 2026. Lifetime open-market purchases: $7.91M. Historical track record: 4/5 stars across 50 tracked purchases.
Every recent SEC Form 4 transaction Phillip Md Et Al Frost has reported, most recent first.
InsiderAlpha computes a forward-return-based score for every insider with enough Form 4 purchase history. The metrics below reflect realized performance after each tracked open-market purchase.
| Metric | Value |
|---|---|
| InsiderAlpha rating | ★★★★☆ (4/5) |
| Total purchases tracked | 50 |
| Purchases with forward-return data | 50 |
| 30-day win rate | 64% |
| 90-day win rate | 28% |
| Avg 5-day return | +2.17% |
| Avg 30-day return | +1.23% |
| Avg 90-day return | -1.48% |
| Best 30-day return |
InsiderAlpha's records for Phillip Md Et Al Frost go back to 2024: 31 primary Form 4 filings, an average of 10.3 per year. The typical open-market purchase is $152K (52 buys totaling $7.91M). The largest single buy on record is $1.50M of FLNT in 2024. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Phillip Md Et Al Frost has no co-filers on record, so these are insiders with the largest open-market activity across the market in the last 90 days.
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Phillip Md Et Al Frost is a corporate insider, tracked as Director, 10% Owner of Cocrystal Pharma, Inc. (COCP). InsiderAlpha holds 31 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
2 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 52 open-market purchases ($7.91M) and 0 open-market sales across all tracked filings.
Across 50 tracked purchases, Phillip Md Et Al Frost averaged +1.2% avg 30-day return with a 64% 30-day win rate. InsiderAlpha rates the track record at 4/5 stars.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
$COCP Cocrystal Pharma, Inc.20.0K shares @ $1.00$20K
| +13.60% |